$KITE Form 8-K

0
740

Form 8-K for KITE PHARMA, INC.


5-Nov-2015

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.On November 5, 2015, Kite Pharma, Inc. (“Kite”) issued a press release announcing its abstract presentations for the 57th Annual Meeting of the American Society of Hematology (“ASH”) in Orlando, Florida, on December 5-8, 2015. Kite plans to present top-line data at the ASH Annual Meeting from the Phase 1 portion of its multicenter Phase 1-2 clinical trial (ZUMA-1) of its lead product candidate, KTE-C19, in patients with aggressive, refractory non-Hodgkin’s lymphoma. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

The following exhibit is filed as part of this Current Report:

99.1 Press Release of Kite issued November 5, 2015.

LEAVE A REPLY

Please enter your comment!
Please enter your name here